Delivery Order SPE2DB22D2211-SPE2DB25FSDUY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,971.47 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. The contract, awarded on August 12, 2025, with completion targeted for August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed this order through its Corporate Office division. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,499.03 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml, a human growth hormone medication. The contract, issued on July 21, 2025, with completion targeted for July 22, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $3,492.30 delivery order to AmerisourceBergen Drug Corp for Norditropin Flexpro 15 mg/1.5 mL, a human growth hormone medication. This contract is classified as a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and was awarded on August 21, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This...
- The Defense Logistics Agency awarded a $21,466.53 delivery order to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order valued at $22,018.26 to AmerisourceBergen Drug Corp for Norditropin Flexpro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The contract specifies performance at the vendor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,259.34 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a delivery order valued at $13,604.02 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,764.09 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 ml, a human growth hormone medication used to treat growth disorders and related conditions. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order is valued at $7,045.08 and carries an ultimate completion date of August 22, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $2,283.33 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDUYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,047.69 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone treatment. The contract is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, issued on August 27, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded to the prime contractor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company functions as a critical vendor for federal medical procurement, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract structure that encompasses multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/27/25 |